{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T07:53:27Z","timestamp":1772956407055,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijcrp.2025.200486","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:02:33Z","timestamp":1754438553000},"page":"200486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of chronic kidney disease on the antithrombotic strategies and outcomes in patients with acute coronary syndromes and atrial fibrillation: Insights from STAR-ACS study"],"prefix":"10.1016","volume":"27","author":[{"given":"Kentaro","family":"Yasuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7098-9406","authenticated-orcid":false,"given":"Hiroshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuko","family":"Nojiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Chikata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Daida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2025.200486_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European society of cardiology: cardiovascular disease statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200486_bib2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehn579","article-title":"Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications","volume":"30","author":"Schmitt","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200486_bib3","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/STROKEAHA.116.014422","article-title":"Renal function and the risk of stroke and bleeding in patients with atrial fibrillation: an observational cohort study","volume":"47","author":"Bonde","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/j.ijcrp.2025.200486_bib4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.113.003628","article-title":"Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (randomized evaluation of long-term anticoagulation therapy) trial analysis","volume":"129","author":"Hijazi","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2025.200486_bib5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2025.200486_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028496","article-title":"Association of chronic kidney disease with atrial fibrillation in the general adult population: a nationwide population-based study","volume":"12","author":"Kim","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2025.200486_bib7","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2025.200486_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000533970","article-title":"The treatment of coronary artery disease in patients with chronic kidney disease: gaps, challenges, and solutions","volume":"10","author":"Losin","year":"2024","journal-title":"Kidney Dis."},{"key":"10.1016\/j.ijcrp.2025.200486_bib9","article-title":"Real-world antithrombotic strategies in patients with atrial fibrillation and recently developed acute coronary syndrome","volume":"24","author":"Iwata","year":"2025","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"10.1016\/j.ijcrp.2025.200486_bib10","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/jth.15048","article-title":"Definition of major bleeding: prognostic classification","volume":"18","author":"Franco","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijcrp.2025.200486_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2011.11.040","article-title":"Impact of noncardiac comorbidities on morbidity and mortality in a predominantly Male population with heart failure and preserved versus reduced ejection fraction","volume":"59","author":"Ather","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200486_bib12","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ahj.2003.12.010","article-title":"Renal insufficiency and mortality from acute coronary syndromes","volume":"147","author":"Masoudi","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcrp.2025.200486_bib13","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1538-7836.2011.04347.x","article-title":"Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs","volume":"9","author":"Kooiman","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ijcrp.2025.200486_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ccep.2020.11.001","article-title":"Renal disease and atrial fibrillation","volume":"13","author":"Stefil","year":"2021","journal-title":"Card Electrophysiol Clin."},{"key":"10.1016\/j.ijcrp.2025.200486_bib15","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2011.08.051","article-title":"Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease","volume":"58","author":"Basra","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200486_bib16","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1093\/ndt\/gft103","article-title":"Chronic kidney disease is associated with increased platelet activation and poor response to antiplatelet therapy","volume":"28","author":"Gremmel","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ijcrp.2025.200486_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1681\/ASN.2010020220","article-title":"Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention","volume":"22","author":"Htun","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcrp.2025.200486_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12882-019-1499-3","article-title":"Effect of antiplatelet therapy on cardiovascular and kidney outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"20","author":"Su","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ijcrp.2025.200486_bib19","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.jcin.2017.02.047","article-title":"Associations between chronic kidney disease and outcomes with use of prasugrel versus clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the PROMETHEUS study","volume":"10","author":"Baber","year":"2017","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcrp.2025.200486_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jjcc.2016.07.017","article-title":"Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patients","volume":"69","author":"Nishi","year":"2017","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200486_bib21","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1708454","article-title":"Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation","volume":"377","author":"Cannon","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200486_bib22","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","article-title":"Prevention of bleeding in patients with atrial fibrillation undergoing PCI","volume":"375","author":"Gibson","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200486_bib23","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1817083","article-title":"Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation","volume":"380","author":"Lopes","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2025.200486_bib24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.amjcard.2019.10.033","article-title":"Safety and efficacy of direct oral anticoagulants versus warfarin in patients with chronic kidney disease and atrial fibrillation","volume":"125","author":"Makani","year":"2020","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200486_bib25","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/heartjnl-2016-309266","article-title":"Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease","volume":"103","author":"Yang","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ijcrp.2025.200486_bib26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1053\/j.gastro.2016.12.018","article-title":"Gastrointestinal safety of direct oral anticoagulants: a large population-based study","volume":"152","author":"Abraham","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijcrp.2025.200486_bib27","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.2215\/CJN.01260210","article-title":"Effect of kidney disease on acute coronary syndrome","volume":"5","author":"Rodrigues","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcrp.2025.200486_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001303","article-title":"Incident atrial fibrillation and risk of death in adults with chronic kidney disease","volume":"3","author":"Bansal","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2025.200486_bib29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000368422","article-title":"Clinical significance of chronic kidney disease and atrial fibrillation on morbidity and mortality in patients with acute myocardial infarction","volume":"40","author":"Hwang","year":"2014","journal-title":"Am. J. Nephrol."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525001242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525001242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:06:56Z","timestamp":1772921216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487525001242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"alternative-id":["S2772487525001242"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200486","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of chronic kidney disease on the antithrombotic strategies and outcomes in patients with acute coronary syndromes and atrial fibrillation: Insights from STAR-ACS study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200486"}}